Evercore ISI analyst David Motemaden raised the firm’s price target on Marsh McLennan to $187 from $184 and keeps an In Line rating on the shares. The firm has lowered targets across the commercial lines insurers to reflect lower P/Es given the decelerating pricing environment "at a time when we are incrementally more negative on the loss cost environment," the analyst tells investors in a preview note for the P&C insurer space.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MMC:
